Public health
fromwww.bbc.com
12 hours agoLondon weight loss drug access 'unequal' - report
Slow NHS rollout of weight loss drugs creates a two-tier system where Londoners resort to unsafe, counterfeit, or expensive private alternatives.
The US Food and Drug Administration has approved a pill version of the drug Wegovy from Novo Nordisk as a treatment for weight loss. The pill was approved for chronic weight management in adults with obesity or overweight and at least one related health condition. The oral medication contains semaglutide, the same active ingredient in Wegovy and Ozempic, which is also made by Novo Nordisk and primarily prescribed for type 2 diabetes.